Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue Ocean

PR Newswire September 8, 2022

Tetra (TSX:TBP) to develop an oral COVID-19 drug

Caroline Egan  September 6, 2022

IIROC Trade Resumption - TBP

Canada NewsWire September 6, 2022

Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients

PR Newswire September 6, 2022

IIROC Trading Halt - TBP

Canada NewsWire September 6, 2022

Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean

PR Newswire August 11, 2022

Tetra Bio-Pharma (TSX:TBP) shares preclinical results from COVID 19 infection studies

Caroline Egan  August 10, 2022

Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections

PR Newswire August 10, 2022

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF(TM), a Potential Multimillion Dollar Prescription Drug

PR Newswire July 12, 2022

Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update

PR Newswire June 6, 2022

Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting

Canada NewsWire May 31, 2022

Tetra Bio-Pharma Appoints Chief Financial Officer

PR Newswire May 30, 2022

The StockTalk Cannabis Report: May 20, 2022

Dave Jackson May 20, 2022

Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD

PR Newswire May 18, 2022

Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate

PR Newswire May 17, 2022

Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology

PR Newswire May 10, 2022

Tetra Bio-Pharm (TSX:TBP) and Cannvalate enter into partnership

Caroline Egan  May 5, 2022

Tetra Bio-Pharma and Cannvalate Enter Into Partnership

PR Newswire May 5, 2022

The StockTalk Cannabis Report: April 29, 2022

Dave Jackson April 29, 2022

The StockTalk Cannabis Report: April 22, 2022

Dave Jackson April 22, 2022